Literature DB >> 10707859

Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation.

M C Hou1, H C Lin, F Y Lee, F Y Chang, S D Lee.   

Abstract

BACKGROUND/AIMS: Endoscopic variceal ligation is superior to sclerotherapy because of its lower rebleeding and complication rates. However, ligation is not without drawbacks due to a higher tendency to variceal recurrence. We conducted a randomized cohort study to delineate the long-term history of variceal recurrence following ligation and sclerotherapy, and to clarify the impact of recurrence on rebleeding and on the consumption of endoscopic treatment resources.
METHODS: Two hundred cirrhotic patients with esophageal variceal bleeding were randomized to undergo maintenance endoscopic variceal sclerotherapy or ligation.
RESULTS: One hundred and forty-one patients achieved variceal eradication and were regularly followed up for 2.2 to 6.7 (mean: 5.1 +/- 1.2) years. The demographic data, hepatic reserve, bleeding severity, and endoscopic features of both sclerotherapy (n=70) and ligation (n=71) showed no difference. Forty (57.1%) patients who underwent sclerotherapy experienced 58 recurrences of esophageal varices, in contrast to the 46 (64.8%) patients who underwent ligation and experienced 81 episodes of recurrence. Kaplan-Meier analysis showed that within 2 years variceal recurrence was more frequent for ligation than sclerotherapy, and the difference decreased thereafter. Multiple recurrence appeared more common with ligation (1/2/3/4/5 episodes of recurrence: 46/23/8/3/1 vs. 40/14/3/1/0, p=0.08). On multifactorial analysis, the endoscopic treatment method and red wale markings were the two factors determining variceal recurrence. Rebleeding from recurrent esophageal varices was unusual and showed no difference between the two groups (7/58 vs. 6/81, p>0.05). Rebleeding from gastric varices was more common after eradication by sclerotherapy (7/19 vs. 1/16, p=0.085) than by ligation. The number of sessions required for eradication of recurrent varices was no different between the two groups.
CONCLUSIONS: Early recurrence and multiple recurrence of esophageal varices are more likely in patients undergoing endoscopic ligation, compared to sclerotherapy; however, the recurrence did not lead to a higher risk of rebleeding or require more endoscopic treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10707859     DOI: 10.1016/s0168-8278(00)80064-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  22 in total

1.  Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization.

Authors:  Kenji Ohmoto; Naoko Yoshioka; Yasuyuki Tomiyama; Norikuni Shibata; Michihiko Takesue; Koji Yoshida; Makoto Kuboki; Shinichiro Yamamoto
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

2.  The role of collateral veins detected by endosonography in predicting the recurrence of esophageal varices after endoscopic treatment: a systematic review.

Authors:  Laura Masalaite; Jonas Valantinas; Juozas Stanaitis
Journal:  Hepatol Int       Date:  2014-06-15       Impact factor: 6.047

3.  Endoscopic management of esophageal varices.

Authors:  Joaquin Poza Cordon; Consuelo Froilan Torres; Aurora Burgos García; Francisco Gea Rodriguez; Jose Manuel Suárez de Parga
Journal:  World J Gastrointest Endosc       Date:  2012-07-16

4.  Natural history of bleeding after esophageal variceal eradication in patients with extrahepatic portal venous obstruction; a 20-year follow-up.

Authors:  Varghese Thomas; Tony Jose; Sunil Kumar
Journal:  Indian J Gastroenterol       Date:  2010-04-28

5.  Endoscopic ultrasonography assessment of para-esophageal varices predicts efficacy of propranolol in preventing recurrence of esophageal varices.

Authors:  Wei-Chih Liao; Ping-Hsien Chen; Ming-Chih Hou; Chen-Jung Chang; Chien-Wei Su; Han-Chieh Lin; Fa-Yauh Lee
Journal:  J Gastroenterol       Date:  2014-06-08       Impact factor: 7.527

Review 6.  Endoscopic treatments for portal hypertension.

Authors:  Gin-Ho Lo
Journal:  Hepatol Int       Date:  2017-11-07       Impact factor: 6.047

7.  Effect of intravariceal sclerotherapy combined with esophageal mucosal sclerotherapy using small-volume sclerosant for cirrhotic patients with high variceal pressure.

Authors:  De-Run Kong; Jin-Guang Wang; Chen Chen; Fang-Fang Yu; Qiong Wu; Jian-Ming Xu
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

8.  Microwave coagulation versus sclerotherapy after band ligation to prevent recurrence of high risk of bleeding esophageal varices in Child-Pugh's A and B patients.

Authors:  Leonardo Trevizan Monici; José Olympio Meirelles-Santos; Elza Cotrim Soares; Maria Aparecida Mesquita; José Murilo Robilotta Zeitune; Ciro Garcia Montes; Jazon Romilson Souza Almeida; Ademar Yamanaka; Luis Alberto Magna
Journal:  J Gastroenterol       Date:  2009-10-03       Impact factor: 7.527

9.  Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Danielle Roberts; Lawrence Mj Best; Suzanne C Freeman; Alex J Sutton; Nicola J Cooper; Sivapatham Arunan; Tanjia Begum; Norman R Williams; Dana Walshaw; Elisabeth Jane Milne; Maxine Tapp; Mario Csenar; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-10

10.  Impact of variceal eradication on rebleeding and prognosis in cirrhotic patients undergoing secondary prophylaxis.

Authors:  Xing Wang; Jinni Luo; Chuan Liu; Yanna Liu; Xiaoying Wu; Fengping Zheng; Zhuofu Wen; Hong Tian; Xiuqing Wei; Yunwei Guo; Jianzhong Li; Xiaoliang Chen; Jin Tao; Xiaolong Qi; Bin Wu
Journal:  Ann Transl Med       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.